Breast Cancer Core Needle Biopsy Market
完整報告名稱與涵蓋範圍
Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology (MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based (Stereotactic) Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Region, And By Segment Forecasts, 2024-2031.
報告摘要
The worldwide Breast Cancer Core Needle Biopsy Market stood at USD 697.3 Mn in 2023, and is poised to reach USD 1,042.3 Mn by 2031, recording a CAGR of 5.34% from 2024 through 2031.
The Breast Cancer Core Needle Biopsy sector involves a confirmatory procedure that helps in early cancer/tumour diagnosis, resulting in faster recovery, higher survival rates, and lower rates of morbidity and mortality. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Breast Cancer Core Needle Biopsy Market Snapshot
Chapter 4. Global Breast Cancer Core Needle Biopsy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Breast Cancer Core Needle Biopsy Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Technology Estimates & Trend Analysis
5.1. Technology & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following Technology:
5.2.1. MRI-Based Breast Biopsy
5.2.2. Ultrasound-Based Breast Biopsy
5.2.3. Mammography-Based (Stereotactic) Breast Biopsy
5.2.4. CT-Based Breast Biopsy
5.2.5. Other Image Based Breast Biopsy
Chapter 6. Market Segmentation 2: End-Use Estimates & Trend Analysis
6.1. End-Use & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 for the following End-Use:
6.2.1. Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
6.2.2. Pharmaceutical & Biotechnology companies
6.2.3. Academic & Research Institutes
Chapter 7. Breast Cancer Core Needle Biopsy Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by Technology, 2023-2031
7.1.2. North America Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by End-Use, 2023-2031
7.1.3. North America Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by Technology, 2023-2031
7.2.2. Europe Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by End-Use, 2023-2031
7.2.3. Europe Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. France
7.2.3.3. Italy
7.2.3.4. Spain
7.2.3.5. UK
7.2.3.6. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by Technology, 2023-2031
7.3.2. Asia Pacific Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by End-Use, 2023-2031
7.3.3. Asia Pacific Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by Technology, 2023-2031
7.4.2. Latin America Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by End-Use, 2023-2031
7.4.3. Latin America Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA revenue Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by Technology, 2023-2031
7.5.2. MEA Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by End-Use, 2023-2031
7.5.3. MEA revenue Breast Cancer Core Needle Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.5.3.1. GCC Countries
7.5.3.2. South Africa
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Intact Medical Corporation
8.2.2. Ethicon Surgical Technologies
8.2.3. Gallini SRL
8.2.4. Leica Biosystems Nussloch GmbH
8.2.5. Hologic, Inc.
8.2.6. Argon Medical Devices
8.2.7. Encapsule Medical Devices LLC
8.2.8. Cook Medical Incorporated
8.2.9. Becton, Dickinson and Company
8.2.10. C.R. Bard, Inc.
8.2.11. Other Prominent Player
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們